Average Co-Inventor Count = 9.07
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (12 from 290 patents)
2. Osi Pharmaceuticals, Inc. (9 from 118 patents)
3. Arvinas Operations, Inc. (4 from 57 patents)
4. Yale University (3 from 1,325 patents)
5. Arvinas, Inc. (2 patents)
25 patents:
1. 12264157 - Compounds and methods for the enhanced degradation of targeted proteins
2. 12054493 - Hepatitis B antiviral agents
3. 11512083 - Compounds and methods for the enhanced degradation of targeted proteins
4. 11352351 - Compounds and methods for the targeted degradation of androgen receptor
5. 10934306 - Hepatitis B antiviral agents
6. 10738035 - Hepatitis B antiviral agents
7. 10730870 - Compounds and methods for the enhanced degradation of targeted proteins
8. 10702528 - Hepatitis B antiviral agents
9. 10640511 - Hepatitis B antiviral agents
10. 10538532 - Hepatitis B antiviral agents
11. 10442788 - Hepatitis B antiviral agents
12. 10301255 - Hepatitis B antiviral agents
13. 10280175 - Hepatitis B antiviral agents
14. 10189846 - Hepatitis B antiviral agents
15. 10179131 - Hepatitis B antiviral agents